Validity, reliability, responsiveness, and interpretability of the Recap of atopic eczema (RECAP) questionnaire.

Junfen Zhang Aviël Ragamin Geertruida L E Romeijn Laura Loman Jart Ate Franke Oosterhaven Marie-Louise A Schuttelaar

Published in: The British journal of dermatology (2023)

The RECAP has good single-score validity, moderate responsiveness and excellent reliability. This study fills a gap in the interpretability of the RECAP. Our results indicate a threshold of ≥6 points to identify patients whose AD is 'not under control', while an improvement of ≥4 points represents a clinically important change. Given its endorsement by the Harmonising Outcome Measures for Eczema (HOME) initiatives, the results of this study support the integration of RECAP into both routine clinical practice and research settings.

Keyphrases

clinical practice
healthcare
newly diagnosed
end stage renal disease
atopic dermatitis
patient reported outcomes